GlassScriptPhysician profile
Mohamed Dafalla
NPI 1730507625
$8,736.67
in general payments reported to CMS, 2019-2025
39 companies · $2,898 in 2025
The $2,898 reported for 2025 was more than what 83% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2022: $1,289 · 2023: $1,970 · 2024: $2,170 · 2025: $2,898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,721 · Consulting Fee: $175 · Education: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,721.23 |
| Consulting Fee | $175.00 |
| Education | $142.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $895.47 | 2019-2025 | Evenity, Prolia, Prolia |
| Lilly USA, LLC | $747.08 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Sanofi-Aventis U.S. LLC | $687.82 | 2019-2025 | |
| Dexcom, INC. | $659.42 | 2022-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Novo Nordisk INC | $646.99 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic, INC. | $631.42 | 2022-2025 | Minimed 780g, Minimed 770g |
| Corcept Therapeutics | $511.37 | 2022-2025 | Korlym |
| Insulet Corporation | $481.68 | 2023-2025 | Omnipod, Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $416.17 | 2022-2025 | |
| Xeris Pharmaceuticals, INC. | $401.30 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Tandem Diabetes Care, INC. | $290.78 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $277.01 | 2019-2025 | Jardiance |
| Abbott Laboratories | $276.27 | 2022-2025 | Freestyle Libre 3 |
| Beta Bionics, INC. | $261.40 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Abbvie INC. | $231.75 | 2022-2025 | Synthroid, Ubrelvy |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Dafalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.